Rejection sensitivity and mu opioid receptor dynamics associated with mood alterations in response to social feedback

Psychiatry Res Neuroimaging. 2022 Aug:324:111505. doi: 10.1016/j.pscychresns.2022.111505. Epub 2022 Jun 6.

Abstract

Rejection sensitivity (RS) is the heightened expectation or perception of social rejection and is a feature of many psychiatric disorders. As endogenous opioid pathways have been implicated in response to social rejection and reward, we hypothesize that RS will be negatively associated with mu opioid receptor (MOR) baseline binding and activity during rejection and acceptance stimuli. In exploratory analyses, we assessed the relationships between MOR activity and changes in mood and self-esteem before and after stimuli. Healthy participants, N = 75 (52% female), completed rejection and acceptance tasks during [11C]carfentanil positron emission tomography (PET) scans. MOR activity in the amygdala, midline thalamus, anterior insula, and nucleus accumbens (NAc) was evaluated. RS was not related to MOR baseline binding potential or activity during acceptance or rejection tasks in any region. Increased MOR activity in the NAc was associated with increase in ratings of self-esteem and positive mood during the period between acceptance task administration and approximately 5 min after the task completion. Our results suggest that endogenous opioid response to social rejection is independent of RS in healthy individuals. MOR activity in the NAc was associated with increase self-esteem and positive mood after experiencing social feedback, warranting further investigation.

Keywords: Mood; Nucleus accumbens; Positron emission tomography; Self-esteem; Social acceptance; [(11)C] Carfentanil.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Analgesics, Opioid*
  • Feedback
  • Female
  • Humans
  • Male
  • Positron-Emission Tomography / methods
  • Receptors, Opioid, mu* / metabolism
  • Reward

Substances

  • Analgesics, Opioid
  • Receptors, Opioid, mu